Moxonidine use in non-complicated hypertensive crisis
https://doi.org/10.18705/1607-419X-2010--6-
Abstract
Objective. To examine efficacy of moxonidine in non-complicated hypertensive crisis. Design and methods. Twenty hypertensive patients, including 11 males and 9 females (mean aged 51,3 ± 7,2 years), were examined. Systolic blood pressure (BP) was 206,7 ± 3,1 mmHg and diastolic BP was 104,6 ± 3,4 mmHg. Ambulatory BP monitoring (ABPM) was performed in all patients. 400 mg of moxonidine once daily was prescribed to all patients. Results. Systolic and diastolic BP was reduced by 20,0 and 11,9 % respectively (within 2 hour),and by 24,4 and 17,2 % respectively within the next 2 to6 hours. Conclusions. Moxonidine can be used in non-complicated hypertensive crisis. Our data indicate that moxonidine is generally welltolerated.
About the Authors
V. V. Safronova
Republic Cardiological Сlinic, Izhevsk
Russian Federation
Russian Federation
Yu. V. Chernykh
Izhevsk Medical Academy, Izhevsk
Russian Federation
Russian Federation
D. V. Timonin
Republic Cardiological Сlinic, Izhevsk
Russian Federation
Russian Federation
S. P. Baranova
Republic Cardiological Сlinic, Izhevsk
Russian Federation
Russian Federation
A. G. Bolotnikov
Republic Cardiological Сlinic, Izhevsk
Russian Federation
Russian Federation
R. T. Rizvanova
Republic Cardiological Сlinic, Izhevsk
Russian Federation
Russian Federation
References
1. Шальнова С.А., Баланова Ю.А., Константинов В.В. и др. Артериальная гипертония: распространенность, осведомленность, прием антигипертензивных препаратов и эффективность лечения среди населения Российской Федерации // Рос. Кардиол. журн. - 2006. - № 4. - С. 45-51.
2.
3. Терещенко С.Н. Гипертонические кризы, современные принципы терапии // Consilium medicum. - 2004. - Т. 6, № 11. - С. 867-870.
4.
5. Чазова И.Е., Ратова Л.Г. Роль суточного мониторирования артериального давления в оценке эффективности антигипертензивной терапии // Consilium medicum, прил. «Системные гипертензии». - 2007. - № 1. - С. 18-26.
6.
7. Fratolla A., Parati G., Cuspidi C. et al. Prognostic value of 24-hour pressure variability // Hypertension. - 1993. - № 11. - P. 1133-1137.
8.
9. Verdecchia P. Risk of cardiovascular disease in relation to achieved office and ambulatory blood pressure control in treated hypertensive subjects // Am. J. Coll. Cardiol. - 2002. - Vol. 39, № 5. - P. 878-885.
Review
For citations:
Safronova V.V., Chernykh Yu.V., Timonin D.V., Baranova S.P., Bolotnikov A.G., Rizvanova R.T. Moxonidine use in non-complicated hypertensive crisis. "Arterial’naya Gipertenziya" ("Arterial Hypertension"). 2010;16(6):549-551. (In Russ.) https://doi.org/10.18705/1607-419X-2010--6-
Views:
6232
Email this article 